Diagnosis and management of an endometrial cancer patient with Cowden syndrome
- PMID: 34446268
- PMCID: PMC8515352
- DOI: 10.1016/j.ygyno.2021.08.008
Diagnosis and management of an endometrial cancer patient with Cowden syndrome
Abstract
Somatic PTEN alterations are common in endometrial carcinoma (EC), but in rare cases PTEN mutations are associated with inherited syndromes. Here, we present a case of Cowden syndrome-associated EC. We discuss clinical, pathologic and molecular features of her tumor and PTEN-mutated EC, inherited syndromes predisposing to EC and PTEN-targeted therapies.
Keywords: Cowden syndrome; Germline; PTEN mutation; Pathology; Targeted therapy.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest Y. Liu reports grants from AstraZeneca and GSK/Tesaro, outside the submitted work. NRA-R reports grants from Stryker/Novadaq and GRAIL paid to the institution, outside the submitted work. C. Aghajanian reports grants from Clovis, Genentech, AbbVie and AstraZeneca, and membership of advisory boards of Tesaro, Eisai/Merck, Mersana Therapeutics, Roche/Genentech, Abbvie, AstraZeneca/Merck and Repare Therapeutics, all outside the submitted work. B. Weigelt reports ad hoc membership of the advisory board of Repare Therapeutics, outside the scope of this study. The remaining authors have no conflicts of interest to declare.
Figures
References
-
- WHO Classification of Tumours Editorial Board. Female Genital Tumours. 5 ed; vol 4. Lyon, France: International Agency for Research on Cancer (IARC). 2020.
-
- Pallares J, Bussaglia E, Martinez-Guitarte JL, Dolcet X, Llobet D, Rue M, et al. Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities. Mod Pathol. 2005;18:719–27. - PubMed
-
- Maiques O, Santacana M, Valls J, Pallares J, Mirantes C, Gatius S, et al. Optimal protocol for PTEN immunostaining; role of analytical and preanalytical variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues. Hum Pathol. 2014;45:522–32. - PubMed
-
- Lac V, Nazeran TM, Tessier-Cloutier B, Aguirre-Hernandez R, Albert A, Lum A, et al. Oncogenic mutations in histologically normal endometrium: the new normal? J Pathol. 2019;249:173–81. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
